• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Obinutuzumab monotherapy in previously untreated chronic lymphocytic leukemia.

作者信息

Gay Nathan D, Kozin Eliana, Okada Craig, Danilov Alexey V, Spurgeon Stephen

机构信息

a Oregon Health and Science University , Portland , OR , USA.

b Tuality Healthcare , Portland , OR , USA.

出版信息

Leuk Lymphoma. 2018 Sep;59(9):2258-2260. doi: 10.1080/10428194.2017.1410890. Epub 2017 Dec 18.

DOI:10.1080/10428194.2017.1410890
PMID:29249186
Abstract
摘要

相似文献

1
Obinutuzumab monotherapy in previously untreated chronic lymphocytic leukemia.奥比妥珠单抗单药治疗初治慢性淋巴细胞白血病
Leuk Lymphoma. 2018 Sep;59(9):2258-2260. doi: 10.1080/10428194.2017.1410890. Epub 2017 Dec 18.
2
Sweet-Like Eruption Associated With Obinutuzumab Therapy for Chronic Lymphocytic Leukemia.与奥滨尤妥珠单抗治疗慢性淋巴细胞白血病相关的类甜疹
JAMA Dermatol. 2017 Jan 1;153(1):108-110. doi: 10.1001/jamadermatol.2016.3355.
3
Obinutuzumab for the treatment of chronic lymphocytic leukemia and other B-cell lymphoproliferative disorders.奥滨尤妥珠单抗用于治疗慢性淋巴细胞白血病及其他B细胞淋巴增殖性疾病。
Expert Opin Biol Ther. 2017 Nov;17(11):1463-1470. doi: 10.1080/14712598.2017.1377178. Epub 2017 Sep 11.
4
Venetoclax and obinutuzumab for frontline treatment of chronic lymphocytic leukemia.维奈托克联合奥滨尤妥珠单抗一线治疗慢性淋巴细胞白血病。
Blood. 2019 Nov 14;134(20):1691-1696. doi: 10.1182/blood.2019001750.
5
Management of patients with previously untreated chronic lymphocytic leukaemia with obinutuzumab and chlorambucil.用奥妥珠单抗和苯丁酸氮芥治疗既往未经治疗的慢性淋巴细胞白血病患者
Intern Med J. 2017 Jul;47 Suppl 4:5-10. doi: 10.1111/imj.13493.
6
Evaluation of safety outcomes with transitioning obinutuzumab from standard rate to short duration infusion in patients with chronic lymphocytic leukemia.评估慢性淋巴细胞白血病患者将奥妥珠单抗从标准输注速率转换为短疗程输注后的安全性结果。
Leuk Lymphoma. 2024 Aug;65(8):1198-1199. doi: 10.1080/10428194.2024.2341999. Epub 2024 Apr 22.
7
Obinutuzumab: a novel anti-CD20 monoclonal antibody for previously untreated chronic lymphocytic leukemia.奥滨尤妥珠单抗：一种用于既往未治疗的慢性淋巴细胞白血病的新型抗CD20单克隆抗体。
Ann Pharmacother. 2014 Oct;48(10):1356-61. doi: 10.1177/1060028014543271. Epub 2014 Jul 18.
8
Obinutuzumab in the treatment of autoimmune haemolytic anaemia and immune thrombocytopenia in patients with chronic lymphocytic leukaemia/small lymphocytic lymphoma.奥妥珠单抗治疗慢性淋巴细胞白血病/小淋巴细胞淋巴瘤患者的自身免疫性溶血性贫血和免疫性血小板减少症
Br J Haematol. 2021 Jan;192(1):e1-e4. doi: 10.1111/bjh.17105. Epub 2020 Oct 23.
9
Progressive multifocal leukoencephalopathy developing after obinutuzumab treatment for chronic lymphocytic leukemia.在使用奥滨尤妥珠单抗治疗慢性淋巴细胞白血病后发生的进行性多灶性白质脑病。
Ann Hematol. 2019 Jun;98(6):1509-1510. doi: 10.1007/s00277-018-3552-x. Epub 2018 Nov 13.
10
Obinutuzumab induces depletion of NK cells in patients with chronic lymphocytic leukemia.奥妥珠单抗可导致慢性淋巴细胞白血病患者的自然杀伤细胞耗竭。
Immunotherapy. 2018 Mar 1;10(6):491-499. doi: 10.2217/imt-2017-0147.

引用本文的文献

1
Chronic lymphocytic leukemia treatment algorithm 2022.2022 年慢性淋巴细胞白血病治疗算法
Blood Cancer J. 2022 Nov 29;12(11):161. doi: 10.1038/s41408-022-00756-9.
2
Use of obinutuzumab for refractory autoimmune thrombocytopenia secondary to CLL.奥滨尤妥珠单抗用于治疗慢性淋巴细胞白血病继发的难治性自身免疫性血小板减少症。
EJHaem. 2020 Aug 12;1(1):368-370. doi: 10.1002/jha2.78. eCollection 2020 Jul.
3
Retreatment with obinutuzumab: An addition to the therapeutic landscape of chronic lymphocytic leukemia.奥妥珠单抗再治疗：慢性淋巴细胞白血病治疗领域的新补充。
SAGE Open Med Case Rep. 2019 Jan 16;7:2050313X18823917. doi: 10.1177/2050313X18823917. eCollection 2019.
4
Chronic lymphocytic leukemia treatment algorithm 2018.2018 年慢性淋巴细胞白血病治疗算法。
Blood Cancer J. 2018 Oct 3;8(10):93. doi: 10.1038/s41408-018-0131-2.